Zhejiang Taimei Medical Technology Co., Ltd. (stock code: 02576) announced on November 4, 2025, that it repurchased 167,400 H shares on the Hong Kong Stock Exchange. This volume represents approximately 0.08% of its then-existing issued shares (excluding treasury shares).

Following the repurchase, the closing balance of issued shares (excluding treasury shares) as of November 4, 2025, stood at 200,425,133, while 167,400 shares are held as treasury shares. According to the report, the highest repurchase price was HKD 4.24 per share, and the total amount paid was HKD 704,008, with the lowest price at HKD 4.

The company was authorized on June 13, 2025, to repurchase up to 20,059,253 shares, and the 167,400 shares bought back so far represent approximately 0.83% of the authorized volume. The moratorium period, during which no new shares may be issued or transferred from treasury, extends up to December 4, 2025.